Living Financial Statements From 2010 to 2024
| LVCLF Stock | USD 0 0.00 0.00% |
Check Living Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Living Cell's main balance sheet or income statement drivers, such as , as well as many indicators such as . Living financial statements analysis is a perfect complement when working with Living Cell Valuation or Volatility modules.
Living |
Living Cell Technologies Company Return On Asset Analysis
Living Cell's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Living Cell Return On Asset | -0.31 |
Most of Living Cell's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Living Cell Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Living Cell Technologies has a Return On Asset of -0.3084. This is 96.48% lower than that of the Healthcare sector and 98.69% lower than that of the Biotechnology industry. The return on asset for all United States stocks is 120.29% higher than that of the company.
Living Cell Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Living Cell's current stock value. Our valuation model uses many indicators to compare Living Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Living Cell competition to find correlations between indicators driving Living Cell's intrinsic value. More Info.Living Cell Technologies is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Living Cell's earnings, one of the primary drivers of an investment's value.About Living Cell Financial Statements
Living Cell stakeholders use historical fundamental indicators, such as Living Cell's revenue or net income, to determine how well the company is positioned to perform in the future. Although Living Cell investors may analyze each financial statement separately, they are all interrelated. For example, changes in Living Cell's assets and liabilities are reflected in the revenues and expenses on Living Cell's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Living Cell Technologies. Please read more on our technical analysis and fundamental analysis pages.
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. The company was founded in 1987 and is based in Sydney, Australia. Living Cell operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Living Pink Sheet
Living Cell financial ratios help investors to determine whether Living Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Living with respect to the benefits of owning Living Cell security.